BioGaia AB (BIOGY)
11.50
0.00 (0.00%)
USD |
OTCM |
Jul 02, 16:00
BioGaia Net Income (Quarterly): 11.75M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.75M |
| December 31, 2023 | 6.344M |
| September 30, 2023 | 9.410M |
| June 30, 2023 | 7.666M |
| March 31, 2023 | 11.12M |
| December 31, 2022 | 13.05M |
| September 30, 2022 | 7.583M |
| June 30, 2022 | 8.028M |
| March 31, 2022 | 8.190M |
| December 31, 2021 | 4.334M |
| September 30, 2021 | 6.119M |
| June 30, 2021 | 6.509M |
| March 31, 2021 | 6.024M |
| December 31, 2020 | 4.474M |
| September 30, 2020 | 2.314M |
| June 30, 2020 | 8.175M |
| March 31, 2020 | 4.341M |
| December 31, 2019 | 5.473M |
| September 30, 2019 | 3.969M |
| June 30, 2019 | 6.465M |
| March 31, 2019 | 3.896M |
| December 31, 2018 | 6.306M |
| September 30, 2018 | 5.753M |
| June 30, 2018 | 7.250M |
| March 31, 2018 | 5.326M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.811M |
| September 30, 2017 | 5.186M |
| June 30, 2017 | 5.358M |
| March 31, 2017 | 4.805M |
| December 31, 2016 | 5.196M |
| September 30, 2016 | 4.116M |
| June 30, 2016 | 4.698M |
| March 31, 2016 | 12.66M |
| December 31, 2015 | 2.567M |
| September 30, 2015 | 2.435M |
| June 30, 2015 | 4.238M |
| March 31, 2015 | 5.199M |
| December 31, 2014 | 2.408M |
| September 30, 2014 | 2.095M |
| June 30, 2014 | 2.693M |
| March 31, 2014 | 15.05M |
| December 31, 2013 | 2.504M |
| September 30, 2013 | 2.053M |
| June 30, 2013 | 2.332M |
| March 31, 2013 | 2.597M |
| December 31, 2012 | 2.234M |
| September 30, 2012 | 2.054M |
| June 30, 2012 | 2.228M |
| March 31, 2012 | 41.91M |
| December 31, 2011 | 3.026M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
2.314M
Minimum
Sep 2020
13.05M
Maximum
Dec 2022
7.099M
Average
6.509M
Median
Jun 2021
Net Income (Quarterly) Benchmarks
| Abliva AB | -1.753M |
| Karolinska Development AB | 0.0201M |
| Calliditas Therapeutics AB | -23.73M |
| Oncopeptides AB | -3.758M |
| Olink Holding AB | -16.06M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 35.65M |
| Total Expenses (Quarterly) | 21.85M |
| EPS Diluted (Quarterly) | 0.1167 |
| Enterprise Value | 1.012B |
| Gross Profit Margin (Quarterly) | 71.89% |
| Profit Margin (Quarterly) | 32.95% |
| Earnings Yield | 3.04% |
| Operating Earnings Yield | 3.56% |
| Normalized Earnings Yield | 3.040 |